Skip Nav Destination
Indolent and mantle cell NHL: the future is BRIGHT
Abnl(17p) in AML: who will guard the guardian?
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Issue Archive
May 8 2014
Table of Contents
INSIDE BLOOD COMMENTARIES
INSIDE BLOOD COMMENTARY
Indolent and mantle cell NHL: the future is BRIGHT
Clinical Trials & Observations
INSIDE BLOOD COMMENTARY
Abnl(17p) in AML: who will guard the guardian?
Clinical Trials & Observations
BLOOD WORK
PLENARY PAPER
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
Javeed Iqbal,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,George Wright,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Chao Wang,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Andreas Rosenwald,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Randy D. Gascoyne,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Dennis D. Weisenburger,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Timothy C. Greiner,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Lynette Smith,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Shuangping Guo,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Ryan A. Wilcox,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Bin Tean Teh,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Soon Thye Lim,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Soon Yong Tan,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Lisa M. Rimsza,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Elaine S. Jaffe,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Elias Campo,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Antonio Martinez,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Jan Delabie,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Rita M. Braziel,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,James R. Cook,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Raymond R. Tubbs,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,German Ott,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Eva Geissinger,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Philippe Gaulard,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Pier Paolo Piccaluga,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Stefano A. Pileri,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Wing Y. Au,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Shigeo Nakamura,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Masao Seto,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Francoise Berger,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Laurence de Leval,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Joseph M. Connors,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,James Armitage,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Julie Vose,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Wing C. Chan,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project,Louis M. Staudt,for the Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project
REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
Clinical Trials & Observations
Ian W. Flinn,Richard van der Jagt,Brad S. Kahl,Peter Wood,Tim E. Hawkins,David MacDonald,Mark Hertzberg,Yiu-Lam Kwan,David Simpson,Michael Craig,Kathryn Kolibaba,Samar Issa,Regina Clementi,Doreen M. Hallman,Mihaela Munteanu,Ling Chen,John M. Burke
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma
Clinical Trials & Observations
Arne Kolstad,on behalf of the Nordic Lymphoma Group,Anna Laurell,on behalf of the Nordic Lymphoma Group,Mats Jerkeman,on behalf of the Nordic Lymphoma Group,Kirsten Grønbæk,on behalf of the Nordic Lymphoma Group,Erkki Elonen,on behalf of the Nordic Lymphoma Group,Riikka Räty,on behalf of the Nordic Lymphoma Group,Lone Bredo Pedersen,on behalf of the Nordic Lymphoma Group,Annika Loft,on behalf of the Nordic Lymphoma Group,Trond Velde Bogsrud,on behalf of the Nordic Lymphoma Group,Eva Kimby,on behalf of the Nordic Lymphoma Group,Per Boye Hansen,on behalf of the Nordic Lymphoma Group,Unn-Merete Fagerli,on behalf of the Nordic Lymphoma Group,Herman Nilsson-Ehle,on behalf of the Nordic Lymphoma Group,Grete Fossum Lauritzsen,on behalf of the Nordic Lymphoma Group,Anne Kristine Lehmann,on behalf of the Nordic Lymphoma Group,Christer Sundstrom,on behalf of the Nordic Lymphoma Group,Marja-Liisa Karjalainen-Lindsberg,on behalf of the Nordic Lymphoma Group,Elisabeth Ralfkiaer,on behalf of the Nordic Lymphoma Group,Mats Ehinger,on behalf of the Nordic Lymphoma Group,Jan Delabie,on behalf of the Nordic Lymphoma Group,Hans Bentzen,on behalf of the Nordic Lymphoma Group,Jukka Schildt,on behalf of the Nordic Lymphoma Group,Kamelia Kostova-Aherdan,on behalf of the Nordic Lymphoma Group,Henrik Frederiksen,on behalf of the Nordic Lymphoma Group,Peter de Nully Brown,on behalf of the Nordic Lymphoma Group,Christian H. Geisler,on behalf of the Nordic Lymphoma Group
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Clinical Trials & Observations
Jan M. Middeke,Min Fang,Jan J. Cornelissen,Brigitte Mohr,Frederick R. Appelbaum,Michael Stadler,Jaime Sanz,Herrad Baurmann,Gesine Bug,Kerstin Schäfer-Eckart,Ute Hegenbart,Tilmann Bochtler,Christoph Röllig,Friedrich Stölzel,Roland B. Walter,Gerhard Ehninger,Martin Bornhäuser,Bob Löwenberg,Johannes Schetelig
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3
Scott M. Steward-Tharp,Arian Laurence,Yuka Kanno,Alex Kotlyar,Alejandro V. Villarino,Giuseppe Sciume,Stefan Kuchen,Wolfgang Resch,Elizabeth A. Wohlfert,Kan Jiang,Kiyoshi Hirahara,Golnaz Vahedi,Hong-wei Sun,Lionel Feigenbaum,Joshua D. Milner,Steven M. Holland,Rafael Casellas,Fiona Powrie,John J. O'Shea
LYMPHOID NEOPLASIA
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells
Jenny Zhang,Dereje Jima,Andrea B. Moffitt,Qingquan Liu,Magdalena Czader,Eric D. Hsi,Yuri Fedoriw,Cherie H. Dunphy,Kristy L. Richards,Javed I. Gill,Zhen Sun,Cassandra Love,Paula Scotland,Eric Lock,Shawn Levy,David S. Hsu,David Dunson,Sandeep S. Dave
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features
Tianjiao Wang,Andrew L. Feldman,David A. Wada,Ye Lu,Avery Polk,Robert Briski,Kay Ristow,Thomas M. Habermann,Dafydd Thomas,Steven C. Ziesmer,Linda E. Wellik,Thomas M. Lanigan,Thomas E. Witzig,Mark R. Pittelkow,Nathanael G. Bailey,Alexandra C. Hristov,Megan S. Lim,Stephen M. Ansell,Ryan A. Wilcox
MYELOID NEOPLASIA
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
Michelle K. Gleason,Julie A. Ross,Erica D. Warlick,Troy C. Lund,Michael R. Verneris,Andres Wiernik,Stephen Spellman,Michael D. Haagenson,Alexander J. Lenvik,Mark R. Litzow,Pearlie K. Epling-Burnette,Bruce R. Blazar,Louis M. Weiner,Daniel J. Weisdorf,Daniel A. Vallera,Jeffrey S. Miller
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
PLATELETS AND THROMBOPOIESIS
Adherence to the Mediterranean diet is associated with lower platelet and leukocyte counts: results from the Moli-sani study
Marialaura Bonaccio,on behalf of the Moli-sani Project Investigators,Augusto Di Castelnuovo,on behalf of the Moli-sani Project Investigators,Amalia De Curtis,on behalf of the Moli-sani Project Investigators,Simona Costanzo,on behalf of the Moli-sani Project Investigators,Mariarosaria Persichillo,on behalf of the Moli-sani Project Investigators,Maria Benedetta Donati,on behalf of the Moli-sani Project Investigators,Chiara Cerletti,on behalf of the Moli-sani Project Investigators,Licia Iacoviello,on behalf of the Moli-sani Project Investigators,Giovanni de Gaetano,on behalf of the Moli-sani Project Investigators
TRANSPLANTATION
ERRATA
-
Cover Image
Cover Image
Abundant alternatively polarized macrophages, demonstrated here by double immunofluorescent staining for the macrophage markers CD163 (green) and phosphorylated STAT3 (red), are observed in peripheral T-cell lymphoma, not otherwise specified. (DAPI, a nuclear stain, blue). See the article by Wang et al on page 3007.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals